These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26675221)

  • 41. Driving membrane curvature in clathrin-dependent and clathrin-independent endocytosis.
    Lundmark R; Carlsson SR
    Semin Cell Dev Biol; 2010 Jun; 21(4):363-70. PubMed ID: 19931628
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mapping of protein transduction pathways with fluorescent microscopy.
    Räägel H; Säälik P; Langel U; Pooga M
    Methods Mol Biol; 2011; 683():165-79. PubMed ID: 21053129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elucidation of the Cellular Uptake Mechanisms of Polycationic HYDRAmers.
    Russier J; Grillaud M; Bianco A
    Bioconjug Chem; 2015 Aug; 26(8):1484-93. PubMed ID: 26046960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives.
    Patel LN; Zaro JL; Shen WC
    Pharm Res; 2007 Nov; 24(11):1977-92. PubMed ID: 17443399
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Study of the intracellular delivery mechanism of a pH-sensitive peptide modified with enhanced green fluorescent protein.
    Chiu PC; Hsieh PY; Kang JW; Chang PH; Shen LJ
    J Drug Target; 2020 Apr; 28(4):408-418. PubMed ID: 31524004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Target shape dependence in a simple model of receptor-mediated endocytosis and phagocytosis.
    Richards DM; Endres RG
    Proc Natl Acad Sci U S A; 2016 May; 113(22):6113-8. PubMed ID: 27185939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Energy-independent intracellular gene delivery mediated by polymeric biomimetics of cell-penetrating peptides.
    Chae SY; Kim HJ; Lee MS; Jang YL; Lee Y; Lee SH; Lee K; Kim SH; Kim HT; Chi SC; Park TG; Jeong JH
    Macromol Biosci; 2011 Sep; 11(9):1169-74. PubMed ID: 21800428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. On the biomedical promise of cell penetrating peptides: limits versus prospects.
    Foerg C; Merkle HP
    J Pharm Sci; 2008 Jan; 97(1):144-62. PubMed ID: 17763452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted intracellular delivery of therapeutics: an overview.
    Rawat A; Vaidya B; Khatri K; Goyal AK; Gupta PN; Mahor S; Paliwal R; Rai S; Vyas SP
    Pharmazie; 2007 Sep; 62(9):643-58. PubMed ID: 17944316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nuclear delivery of macromolecules: barriers and carriers.
    Belting M; Sandgren S; Wittrup A
    Adv Drug Deliv Rev; 2005 Feb; 57(4):505-27. PubMed ID: 15722161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intracellular transduction and potential of Tat PTD and its analogs: from basic drug delivery mechanism to application.
    Zhang X; Zhang X; Wang F
    Expert Opin Drug Deliv; 2012 Apr; 9(4):457-72. PubMed ID: 22432469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peptide-mediated protein delivery-which pathways are penetrable?
    Räägel H; Säälik P; Pooga M
    Biochim Biophys Acta; 2010 Dec; 1798(12):2240-8. PubMed ID: 20170627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Syndecan-4 Is a Receptor for Clathrin-Mediated Endocytosis of Arginine-Rich Cell-Penetrating Peptides.
    Kawaguchi Y; Takeuchi T; Kuwata K; Chiba J; Hatanaka Y; Nakase I; Futaki S
    Bioconjug Chem; 2016 Apr; 27(4):1119-30. PubMed ID: 27019270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intracellular targeting of polymer-bound drugs for cancer chemotherapy.
    Nori A; Kopecek J
    Adv Drug Deliv Rev; 2005 Feb; 57(4):609-36. PubMed ID: 15722167
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antigen presenting cell-selective drug delivery by glycan-decorated nanocarriers.
    Frenz T; Grabski E; Durán V; Hozsa C; Stępczyńska A; Furch M; Gieseler RK; Kalinke U
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt A):13-7. PubMed ID: 25701806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluating the translocation properties of a new nuclear targeted penetrating peptide using two fluorescent markers.
    Zhang R; Yang XZ; Wang JW; Fu LY; Zhao J; Wang FJ
    J Drug Target; 2015 Jun; 23(5):444-52. PubMed ID: 25609361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
    Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
    Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular interplays involved in the cellular uptake of octaarginine on cell surfaces and the importance of syndecan-4 cytoplasmic V domain for the activation of protein kinase Cα.
    Nakase I; Osaki K; Tanaka G; Utani A; Futaki S
    Biochem Biophys Res Commun; 2014 Apr; 446(4):857-62. PubMed ID: 24632200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glycosaminoglycans in the cellular uptake of drug delivery vectors - bystanders or active players?
    Favretto ME; Wallbrecher R; Schmidt S; van de Putte R; Brock R
    J Control Release; 2014 Apr; 180():81-90. PubMed ID: 24548480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell-penetrating peptides as a novel transdermal drug delivery system.
    Nasrollahi SA; Taghibiglou C; Azizi E; Farboud ES
    Chem Biol Drug Des; 2012 Nov; 80(5):639-46. PubMed ID: 22846609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.